Sanford C. Bernstein Increases BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target to $94.00
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) had its price target lifted by Sanford C. Bernstein from $90.00 to $94.00 in a report released on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the biotechnology company’s stock. Sanford C. Bernstein’s target price would indicate a potential upside of 52.73% from the company’s previous [...]